Humanized mouse models for type 1 diabetes including pancreatic islet transplantation

Hormone and Metabolic Research

Volumn 47, Issue 1, 2015, Pages 43-47

  Rahmig, S ^a   Bornstein, S R ^b   Chavakis, T ^b   Jaeckel, E ^c   Waskow, C ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

autoimmunity; diabetes mellitus type 1; humanized mice; islet transplantation; transplantation

Indexed keywords

ADAPTIVE IMMUNITY; CELL FUNCTION; CELLS BY BODY ANATOMY; HEMATOPOIESIS; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MINIMALLY INVASIVE SURGERY; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; ANIMAL; DIABETES MELLITUS, TYPE 1; DISEASE MODEL; HUMAN; MOUSE; SPECIES DIFFERENCE;

ANIMALIA; MUS; RATTUS; RODENTIA;

ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; SPECIES SPECIFICITY;

EID: 84920727661     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1390446     Document Type: Review

References (51)

1. Mestas J., Hughes C. C. Of mice and not men: differences between mouse and human immunology. J Immunol: 2004; 172 2731 2738
2. Atkinson M. A., Leiter E. H. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med: 1999; 5 601 604
3. Greiner D. L., Rossini A. A., Mordes J. P. Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere. Clin Immunol: 2001; 100 134 143
4. Couzin-Frankel J. Clinical studies. Trying to reset the clock on type 1 diabetes. Science: 2011; 333 819 821
5. Greenbaum C., Atkinson M. A. Persistence is the twin sister of excellence: an important lesson for attempts to prevent and reverse type 1 diabetes. Diabetes: 2011; 60 693 694
6. Herold K. C. Restoring immune balance in type 1 diabetes. Lancet Diabetes Endocrinol: 2013; 1 261 263
7. Butler P. C., Meier J. J., Butler A. E., Bhushan A. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab: 2007; 3 758 768
8. Roep B. O. Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann N Y Acad Sci: 2007; 1103 1 10
9. Coppieters K. T., Dotta F., Amirian N., Campbell P. D., Kay T. W., Atkinson M. A., Roep B. O., von Herrath M. G. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med: 2012; 209 51 60
10. Hunig T. The storm has cleared: lessons from the CD28 superagonist TGN1412 trial. Nat Rev Immunol: 2012; 12 317 318
11. King M., Pearson T., Shultz L. D., Leif J., Bottino R., Trucco M., Atkinson M. A., Wasserfall C., Herold K. C., Woodland R. T., Schmidt M. R., Woda B. A., Thompson M. J., Rossini A. A., Greiner D. L. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol: 2008; 126 303 314
12. Kroon E., Martinson L. A., Kadoya K., Bang A. G., Kelly O. G., Eliazer S., Young H., Richardson M., Smart N. G., Cunnigham J., Agulnick A. D., D'Amour K. A., Carpenter M. K., Baetge E. E. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol: 2008; 26 443 452
13. Zhang D., Jiang W., Liu M., Sui X., Yin X., Chen S., Shi Y., Deng H. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res: 2009; 19 429 438
14. Yoshioka M., Kayo T., Ikeda T., Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes: 1997; 46 887 894
15. Shi Y., Vattem K. M., Sood R., An J., Liang J., Stramm L., Wek R. C. Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control. Mol Cell Biol: 1998; 18 7499 7509
16. Nir T., Melton D. A., Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest: 2007; 117 2553 2561
17. Thorel F., Nepote V., Avril I., Kohno K., Desgraz R., Chera S., Herrera P. L. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature: 2010; 464 1149 1154
18. Brehm M. A., Bortell R., Diiorio P., Leif J., Laning J., Cuthbert A., Yang C., Herlihey M., Burzenski L., Gott B., Foreman O., Powers A. C., Greiner D. L., Shultz L. D. Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice. Diabetes: 2010; 59 2265 2270
19. Shultz L. D., Ishikawa F., Greiner D. L. Humanized mice in translational biomedical research. Nat Rev Immunol: 2007; 7 118 130
20. van Halteren A. G., Kardol M. J., Mulder A., Roep B. O. Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice. Diabetologia: 2005; 48 75 82
21. Cohen J. Toxicology. 'Humanized' mouse detects deadly drug side effects. Science: 2014; 344 244 245
22. Mosier D. E., Gulizia R. J., Baird S. M., Wilson D. B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature: 1988; 335 256 259
23. Shultz L. D., Brehm M. A., Garcia-Martinez J. V., Greiner D. L. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol: 2012; 12 786 798
24. King M., Pearson T., Shultz L. D., Leif J., Bottino R., Trucco M., Atkinson M., Wasserfall C., Herold K., Mordes J. P., Rossini A. A., Greiner D. L. Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity. Ann N Y Acad Sci: 2007; 1103 90 93
25. Brehm M. A., Powers A. C., Shultz L. D., Greiner D. L. Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice. Cold Spring Harbor Perspect Med: 2012; 2 a007757
26. Strowig T., Rongvaux A., Rathinam C., Takizawa H., Borsotti C., Philbrick W., Eynon E. E., Manz M. G., Flavell R. A. Transgenic expression of human signal regulatory protein alpha in Rag2-/-{gamma}c-/- mice improves engraftment of human hematopoietic cells in humanized mice. Proc Natl Acad Sci USA: 2011; 108 13218 13223
27. Legrand N., Huntington N. D., Nagasawa M., Bakker A. Q., Schotte R., Strick-Marchand H., de Geus S. J., Pouw S. M., Böhne M., Voordow A., Weijer K., Di Santo J. P., Spits H. Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Proc Natl Acad Sci USA: 2011; 108 13224 13229
28. Lavender K. J., Pang W. W., Messer R. J., Duley A. K., Race B., Phillips K., Scott D., Peterson K. E., Chan C. K., Dittmer U., Dudek T. BLT-humanized C57BL/6 Rag2-/-gammac-/-CD47-/- mice are resistant to GVHD and develop B and T cell immunity to HIV infection. Blood: 2013; 122 4013 4020
29. Shao L., Feng W., Li H., Gardner D., Luo Y., Wang Y., Liu L., Meng A., Shapless N. E., Zhou D. Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner. Blood: 2014; 123 3105 3115
30. Shen H., Yu H., Liang P. H., Cheng H., XuFeng R., Yuan Y., Peng Z., Smith C. A., Cheng T. An acute negative bystander effect of gamma-irradiated recipients on transplanted hematopoietic stem cells. Blood: 2012; 119 3629 3637
31. Carbonneau C. L., Despars G., Rojas-Sutterlin S., Fortin A., Le O., Hoang T., Beauséjour C. M. Ionizing radiation-induced expression of INK4a/ARF in murine bone marrow-derived stromal cell populations interferes with bone marrow homeostasis. Blood: 2012; 119 717 726
32. Chen Q., Khoury M., Chen J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci USA: 2009; 106 21783 21788
33. Brehm M. A., Racki W. J., Leif J., Burzenski L., Hosur V., Wetmore A., Gott B., Herlihy M., Iggnotz R., Dunn R., Shultz L. D., Greiner D. L. Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rgamma null mice is enhanced by transgenic expression of membrane-bound human SCF. Blood: 2012; 119 2778 2788
34. Nicolini F. E., Cashman J. D., Hogge D. E., Humphries R. K., Eaves C. J. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia: 2004; 18 341 347
35. Takagi S., Saito Y., Hijikata A., Tanaka S., Watanabe T., Hasegawa T., Mochizuki S., Kunisawa J., Kiyono H., Koseki H., Ohara O., Saito T., Taniguchi S., Shultz L. D., Ishikava F. Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood: 2012; 119 2768 2777
36. Rongvaux A., Willinger T., Martinek J., Strowig T., Gearty S. V., Teichmann L. L., Saito Y., Marches F., Halene S., Palucka A. K., Manz M. G., Flavell R. A. Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol: 2014; 32 364 372
37. Rongvaux A., Willinger T., Takizawa H., Rathinam C., Auerbach W., Murphy A. J., Valenzuela D. M., Yancopoulos G. D., Eynon E. E., Stevens S., Manz M. G., Flavell R. A. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc Natl Acad Sci USA: 2011; 108 2378 2383
38. Willinger T., Rongvaux A., Takizawa H., Yancopoulos G. D., Valenzuela D. M., Murphy A. J., Auerbach W., Eynon E. E., Stevens S., Manz M. G., Flavell R. A. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci USA: 2011; 108 2390 2395
39. Waskow C., Madan V., Bartels S., Costa C., Blasig R., Rodewald H. R. Hematopoietic stem cell transplantation without irradiation. Nat Meth: 2009; 6 267 269
40. Nocka K., Tan J. C., Chiu E., Chu T. Y., Ray P., Traktman P., Besmer P. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J: 1990; 9 1805 1813
41. Cosgun K. N., Rahmig S., Mende N., Reinke S., Hauber I., Schafer C., Petzold A., Weisbach H., Heidkamp G., Purbojo A., Cesnjevar R., Platz A., Bornhäuser M., Schmitz M., Dudziak D., Hauber J., Kirberg J., Waskow C. Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier. Cell Stem Cell: 2014; 15 227 238
42. Scheeren F. A., Nagasawa M., Weijer K., Cupedo T., Kirberg J., Legrand N., Spits H. T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells. J Exp Med: 2008; 205 2033 2042
43. Yi S., Ji M., Wu J., Ma X., Phillips P., Hawthorne W. J., O'Connell P. J. Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice. Diabetes: 2012; 61 1180 1191
44. Jin X., Wang Y., Hawthorne W. J., Hu M., Yi S., O'Connell P. J. Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells. Transplantation: 2014; 97 30 38
45. Marek-Trzonkowska N., Mysliwiec M., Dobyszuk A., Grabowska M., Techmanska I., Juscinska J., Wujtewicz M. A., Witkovski P., Młynarski W., Balcerska A., Myliwska J., Trzonkowski P. Administration of CD4+CD25highCD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care: 2012; 35 1817 1820
46. Klymiuk N., van Buerck L., Bahr A., Offers M., Kessler B., Wuensch A., Kurome M., Thormann M., Lochner K., Nagashima H., Herbach N., Wanke R., Seissler J., Wolf E. Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes: 2012; 61 1527 1532
47. Traggiai E., Chicha L., Mazzucchelli L., Bronz L., Piffaretti J. C., Lanzavecchia A., Manz M. G. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science: 2004; 304 104 107
48. Melkus M. W., Estes J. D., Padgett-Thomas A., Gatlin J., Denton P. W., Othieno F. A., Wege A. K., Haase A. T., Garcia J. V. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med: 2006; 12 1316 1322
49. Lan P., Tonomura N., Shimizu A., Wang S., Yang Y. G. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood: 2006; 108 487 492
50. Ishikawa F., Yasukawa M., Lyons B., Yoshida S., Miyamoto T., Yoshimoto G., Watanabe T., Akashi K., Shultz L. D., Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood: 2005; 106 1565 1573
51. Ito M., Hiramatsu H., Kobayashi K., Suzue K., Kawahata M., Hioki K., Ueyama Y., Koyanagi Y., Sugamura K., Tsuji K., Heike T., Nakahata T. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood: 2002; 100 3175 3182